PRESS: Fierce Biotech - Forge Biologics

Six months after departing Abeona, Tim Miller, Ph.D., is on his next chapter: Forge Biologics, a gene therapy biotech that’s []Read More from PRESS: Fierce Biotech

10.12.23 Alvotech's failed FDA plant inspection foils Stelara biosim; BMS expands collab with robotic cell therapy manufacturer Cellares - Questex

Bio-ReCell New website

Articles by Zoey Becker's Profile, FiercePharma Journalist

Endpoints News — J&J ends adult RSV vaccine development; The Broad's Feng Zhang outlines bacterial delivery in new paper

Forge Bio's Combo Model for Gene Therapies Attracts $40M in Funding - Forge Biologics

Forge Biologics

Fierce Biotech Summit

Forge Biologics

Forge Biologics

CDMO Ajinomoto forges ahead with Forge Biologics in $620M acquisition

The 25 most influential people in biopharma in 2015